Navigation Links
Researchers ID gene behind primary cervical dystonia, a neck-twisting disorder
Date:3/5/2012

JACKSONVILLE, Fla. Researchers have identified a gene that causes adult-onset primary cervical dystonia, an often-painful condition in which patients' necks twist involuntarily. The discovery by a team from the Jacksonville, Fla., campus of Mayo Clinic and the University of Tennessee Health Sciences Center sheds light on a movement disorder that physicians previously could seldom explain. Their research appears in the Annals of Neurology.

In 1990, a man with a crooked neck came to see Ryan Uitti, M.D., a neurologist then at Mayo Clinic in Rochester, Minn. Dr. Uitti knew about adult-onset primary cervical dystonia, which results in involuntary twisting of the neck to the left or right, backward or forward. Most people who have it suffer from muscle pain and abnormalities in head position. Some don't think it is all that unusual and may not seek medical help, Dr. Uitti says.

"They think they slept wrong at some point, or, because the twisting might straighten out with another maneuver, such as walking backwards, they might actually be accused of being a little crazy," Dr. Uitti says.

Dr. Uitti had been taught that there is usually no explanation for the disorder, when it shows up in adulthood. But working with a team of neurologists who have found the genetic causes of other rare conditions, Dr. Uitti began to investigate.

His patient first said no one in his family had the same problem. Dr. Uitti soon found out that his patient had an identical twin whose head was also twisted, but in the opposite direction. And when Dr. Uitti went to visit their sister, she had the same kind of dystonia. Eventually, seven people in the extended family were diagnosed with this mysterious condition. "I heard a lot of explanations by the family for it, such as that one member got hit by lightning," he says.

In 1994, when Dr. Uitti relocated to Mayo Clinic's campus in Florida, he continued his research into the genetic basis of this neurological disorder, which is also known as spasmodic torticollis. He used the research infrastructure provided by the Morris K. Udall Center of Excellence for Parkinson's Disease Research, funded by the National Institutes of Health, and collaborated with a Mayo team that included Parkinson's gene hunter Zbigniew Wszolek, M.D.

They and researchers from the University of Tennessee Health Sciences Center, with Mark LeDoux, M.D., Ph.D., as the lead neurogeneticist, are reporting the first gene that causes primary cervical dystonia. Their finding is based on genetic material donated by this family the first extended "cohort" identified and others with the condition.

The researchers found a mutation in the CIZ1 gene that makes a protein expressed in certain nerve cells in the brain and which seems to be involved in cell cycle activities. The actual mechanism has not yet been identified, Dr. Uitti says: "It is interesting because the brain tissue of folks with this disorder looks absolutely normal."

Textbooks say that adult-onset primary cervical dystonia affects about 30 of every 100,000 people, but Dr. Uitti believes it is not that rare. "Cervical dystonia is the most common focal, fixed, adult-onset dystonia. But I suspect most people don't seek medical attention for a little bit of neck twisting or tilting," he says.

There are several treatments. Most common is the use of botulinum toxin injections to incapacitate the nerve in the affected muscle, eliminating chronic pain and muscle pulling/contraction.

Dr. Uitti believes CIZ1 is one genetic cause of this disorder, and that other genes will be found. But he is elated that at least one explanation for it has been found. "While it took over 20 years, at least it took place in my lifetime," he says. "This discovery reflects the first genetic cause for this condition ever identified."


'/>"/>

Contact: Kevin Punsky
punsky.kevin@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Researchers find sarcoma tumor immune response with combination therapy
2. Mayo researchers provide atomic view of a histone chaperone
3. Researchers find potential solution to melanomas resistance to vemurafenib
4. Kessler Foundation researchers present at DC Conference on Race, Ethnicity and Disabilities
5. Researchers Spot Genes Behind Macular Degeneration
6. 90 percent of firefighters exhibit symptoms of PTSD according to Ben-Gurion University researchers
7. New blood test for early cancer detection developed by Ben-Gurion University researchers
8. UC Davis MIND Institute researchers to present on autism at AAAS Annual Meeting in Vancouver
9. Nasty superbug is being studied by UB researchers
10. Researchers see differences in Autism brain development as early as 6 months
11. As diabetes emerges, researchers track diseases first steps
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: